13 results on '"Oshima, Junko"'
Search Results
2. Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus
- Author
-
Levy-Lahad, Ephrat, Wasco, Wilma, Poorkaj, Parvoneh, Romano, Donna M., Oshima, Junko, Pettingell, Warren H., Yu, Chang-en, Jondro, Paul D., Schmidt, Stephen D., Wang, Kai, Crowley, Annette C., Fu, Ying-Hui, Guenette, Suzanne Y., Galas, David, Nemens, Ellen, Wijsman, Ellen M., Bird, Thomas D., Schellenberg, Gerard D., and Tanzi, Rudolph E.
- Published
- 1995
3. Review of How Genetic Research on Segmental Progeroid Syndromes Has Documented Genomic Instability as a Hallmark of Aging But Let Us Now Pursue Antigeroid Syndromes!
- Author
-
Martin, George M, Hisama, Fuki M, and Oshima, Junko
- Subjects
HUMAN genetics ,AGING ,SYNDROMES ,CENTENARIANS ,GENETIC mutation ,ALZHEIMER'S disease ,DIABETES ,WERNER'S syndrome ,CORONARY artery disease ,RESEARCH funding ,INBORN errors of metabolism ,COCKAYNE syndrome ,PHENOTYPES ,GENETIC research - Abstract
The purpose of this early contribution to the new Fellows Forum of this pioneering journal for what is now called Geroscience is to provide an example of how the author's interest in using the emerging tools of human genetics has led to strong support for one of the hallmarks of aging-Genomic Instability. We shall also briefly review our emerging interests in the genetic analysis of what we have called Antigeroid Syndromes. While there has been significant progress in that direction via genetic studies of centenarians, the search for genetic pathways that make individuals unusually resistant or resilient to the ravages of specific geriatric disorders has been comparatively neglected. We refer to these disorders as Unimodal Antigeroid Syndromes. It is our hope that our young colleagues will consider research efforts in that direction. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. CTC1 mutations in a Brazilian family with progeroid features and recurrent bone fractures.
- Author
-
Sargolzaeiaval, Forough, Zhang, Jiaming, Schleit, Jennifer, Lessel, Davor, Kubisch, Christian, Precioso, Debora R., Sillence, David, Hisama, Fuki M., Dorschner, Michael, Martin, George M., and Oshima, Junko
- Subjects
NUCLEOTIDE sequencing ,CELL proliferation ,GENETIC mutation ,MITOCHONDRIAL DNA ,GENOMICS - Abstract
Background: Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) is an autosomal recessive disorder caused by pathogenic variants of the conserved telomere maintenance component 1 (CTC1) gene. The CTC1 forms the telomeric capping complex, CST, which functions in telomere homeostasis and replication. Methods: A Brazilian pedigree and an Australian pedigree were referred to the International Registry of Werner Syndrome (Seattle, WA, USA), with clinical features of accelerated aging and recurrent bone fractures. Whole exome sequencing was performed to identify the genetic causes. Results: Whole exome sequencing of the Brazilian pedigree revealed compound heterozygous pathogenic variants in CTC1: a missense mutation (c.2959C>T, p.Arg987Trp) and a novel stop codon change (c.322C>T, p.Arg108*). The Australian patient carried two novel heterozygous CTC1 variants, c.2916G>T, p.Val972Gly and c.2926G>T, p.Val976Phe within the same allele. Both heterozygous variants were inherited from the unaffected father, excluding the diagnosis of CRMCC in this pedigree. Cell biological studies demonstrated accumulation of double strand break foci in lymphoblastoid cell lines derived from the patients. Increased DSB foci were extended to non‐telomeric regions of the genome, in agreement with previous biochemical studies showing a preferential binding of CTC1 protein to GC‐rich sequences. Conclusion: CTC1 pathogenic variants can present with unusual manifestations of progeria accompanied with recurrent bone fractures. Further studies are needed to elucidate the disease mechanism leading to the clinical presentation with intra‐familial variations of CRMCC. Novel CTC1 mutations were identified in patients referred to the international registry of Werner syndrome, presenting features of progeria and recurrent bone fractures. Increased number of DNA damage foci was detected in CTC1 mutants which were extended to whole genome. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions.
- Author
-
Oshima, Junko, Sidorova, Julia M., and Jr.Monnat, Raymond J.
- Subjects
- *
PREMATURE aging (Medicine) , *WERNER'S syndrome , *DNA helicases , *DNA repair , *DNA replication , *GENETIC mutation - Abstract
Werner syndrome (WS) is a prototypical segmental progeroid syndrome characterized by multiple features consistent with accelerated aging. It is caused by null mutations of the WRN gene, which encodes a member of the RECQ family of DNA helicases. A unique feature of the WRN helicase is the presence of an exonuclease domain in its N-terminal region. Biochemical and cell biological studies during the past decade have demonstrated involvements of the WRN protein in multiple DNA transactions, including DNA repair, recombination, replication and transcription. A role of the WRN protein in telomere maintenance could explain many of the WS phenotypes. Recent discoveries of new progeroid loci found in atypical Werner cases continue to support the concept of genomic instability as a major mechanism of biological aging. Based on these biological insights, efforts are underway to develop therapeutic interventions for WS and related progeroid syndromes. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Search and Insights into Novel Genetic Alterations Leading to Classical and Atypical Werner Syndrome.
- Author
-
Oshima, Junko and Hisama, Fuki M.
- Subjects
- *
WERNER'S syndrome , *PREMATURE aging (Medicine) , *GENETIC disorders , *MEDICAL genetics , *GENETIC mutation , *GENETICS - Abstract
Segmental progeroid syndromes are a group of disorders with multiple features resembling accelerated aging. Adult-onset Werner syndrome (WS) and childhood-onset Hutchinson-Gilford progeria syndrome are the best known examples. The discovery of genes responsible for such syndromes has facilitated our understanding of the basic mechanisms of aging as well as the pathogenesis of other common, age-related diseases. Our International Registry of Werner Syndrome accesses progeroid pedigrees from all over the world, including those for whom we have ruled out a mutation at the WRN locus. Cases without WRN mutations are operationally categorized as 'atypical WS' (AWS). In 2003, we identified LMNA mutations among a subset of AWS cases using a candidate gene approach. As of 2013, the Registry has 142 WS patients with WRN mutations, 11 AWS patients with LMNA mutations, and 49 AWS patients that have neither WRN nor LMNA mutations. Efforts are underway to identify the responsible genes for AWS with unknown genetic causes. While WS and AWS are rare disorders, the causative genes have been shown to have much wider implications for cancer, cardiovascular disease and the biology of aging. Remarkably, centenarian studies revealed WRN and LMNA polymorphic variants among those who have escaped various geriatric disorders. © 2014 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
7. LCR-initiated rearrangements at the IDS locus, completed with Alu-mediated recombination or non-homologous end joining.
- Author
-
Oshima, Junko, Lee, Jennifer A, Breman, Amy M, Fernandes, Priscilla H, Babovic-Vuksanovic, Dusica, Ward, Patricia A, Wolfe, Lynne A, Eng, Christine M, and del Gaudio, Daniela
- Subjects
- *
MUCOPOLYSACCHARIDOSIS , *GENETIC mutation , *ETIOLOGY of diseases , *GENETIC code , *DISEASE relapse , *LYSOSOMAL storage diseases - Abstract
Mucopolysaccharidosis type II (MPS II) is caused by mutations in the IDS gene, which encodes the lysosomal enzyme iduronate-2-sulfatase. In ∼20% of MPS II patients the disorder is caused by gross IDS structural rearrangements. We identified two male cases harboring complex rearrangements involving the IDS gene and the nearby pseudogene, IDSP1, which has been annotated as a low-copy repeat (LCR). In both cases the rearrangement included a partial deletion of IDS and an inverted insertion of the neighboring region. In silico analyses revealed the presence of repetitive elements as well as LCRs at the junctions of rearrangements. Our models illustrate two alternative consequences of rearrangements initiated by non-allelic homologous recombination of LCRs: resolution by a second recombination event (that is, Alu-mediated recombination), or resolution by non-homologous end joining repair. These complex rearrangements have the potential to be recurrent and may be present among those MSP II cases with previously uncharacterized aberrations involving IDS. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
8. Regional genomic instability predisposes to complex dystrophin gene rearrangements.
- Author
-
Oshima, Junko, Magner, Daniel B., Lee, Jennifer A., Breman, Amy M., Schmitt, Eric S., White, Lisa D., Crowe, Carol A., Merrill, Michelle, Jayakar, Parul, Rajadhyaksha, Aparna, Eng, Christine M., and del Gaudio, Daniela
- Subjects
- *
GENETIC mutation , *MEMBRANE proteins , *GENETICS , *GENES , *DYSTROPHIN genes , *DUCHENNE muscular dystrophy - Abstract
Mutations in the dystrophin gene ( DMD) cause Duchenne and Becker muscular dystrophies and the majority of cases are due to DMD gene rearrangements. Despite the high incidence of these aberrations, little is known about their causative molecular mechanism(s). We examined 792 DMD/BMD clinical samples by oligonucleotide array-CGH and report on the junction sequence analysis of 15 unique deletion cases and three complex intragenic rearrangements to elucidate potential underlying mechanism(s). Furthermore, we present three cases with intergenic rearrangements involving DMD and neighboring loci. The cases with intragenic rearrangements include an inversion with flanking deleted sequences; a duplicated segment inserted in direct orientation into a deleted region; and a splicing mutation adjacent to a deletion. Bioinformatic analysis demonstrated that 7 of 12 breakpoints combined among 3 complex cases aligned with repetitive sequences, as compared to 4 of 30 breakpoints for the 15 deletion cases. Moreover, the inversion/deletion case may involve a stem-loop structure that has contributed to the initiation of this rearrangement. For the duplication/deletion and splicing mutation/deletion cases, the presence of the first mutation, either a duplication or point mutation, may have elicited the deletion events in an attempt to correct preexisting mutations. While NHEJ is one potential mechanism for these complex rearrangements, the highly complex junction sequence of the inversion/deletion case suggests the involvement of a replication-based mechanism. Our results support the notion that regional genomic instability, aided by the presence of repetitive elements, a stem-loop structure, and possibly preexisting mutations, may elicit complex rearrangements of the DMD gene. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
9. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.
- Author
-
Shurong Huang, Lishan Chen, Libina, Nataliya, Janes, Joel, Martin, George M., Campisi, Judith, and Oshima, Junko
- Subjects
PROGERIA ,RNA ,CORONARY arteries ,ATHEROSCLEROSIS ,GENE therapy ,GENETIC mutation - Abstract
The great majority of cases of the Hutchinson-Gilford progeroid syndrome (HGPS) (“Progeria of Childhood‘’) are caused by a single nucleotide mutation (1824 C->T) in the LMNA gene which encodes lamin A and C, nuclear intermediate filaments that are important components of the nuclear lamina. The resultant mutant protein (Δ50 lamin A) is thought to act in a dominant fashion. We exploited RNA interference technology to suppress Δ50 lamin A expression, with the long range goal of intervening in the pathogenesis of the coronary artery atherosclerosis that typically leads to the death of HGPS patients. Short hairpin RNA (shRNA) constructs were designed to target the mutated pre-spliced or mature LMNA mRNAs, and were expressed in HGPS fibroblasts carrying the 1824 C->T mutations using lentiviruses. One of the shRNAs targeted to the mutated mRNA reduced the expression levels of Δ50 lamin A to 26% or lower. The reduced expression was associated with amelioration of abnormal nuclear morphology, improvement of proliferative potential, and reduction in the numbers of senescent cells. These findings provide a rationale for potential gene therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
10. Lessons from human progeroid syndromes.
- Author
-
Martin, George M. and Oshima, Junko
- Subjects
- *
AGING , *GENETIC mutation , *WERNER'S syndrome , *GENES , *GENETICS - Abstract
Reports that a number of human genes have been identified in which mutations can lead to the acceleration of aging. How studies of these genes and their protein products may lead to a clearer understanding of aging; Mention of age-related diseases, including Alzheimer's disease; Explanation of Werner syndrome, which leads to symptoms such as cataracts, osteoporosis and atherosclerosis; Opinion that senescence results from the waning of the force of natural selection.
- Published
- 2000
- Full Text
- View/download PDF
11. Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts.
- Author
-
Saha, Bidisha, Cypro, Alexander, Martin, George M., and Oshima, Junko
- Subjects
RAPAMYCIN ,DNA damage ,CELL growth ,FIBROBLASTS ,TARGETED drug delivery ,GENETIC mutation ,WERNER'S syndrome - Abstract
Werner syndrome (WS), caused by mutations at the WRN helicase gene, is a progeroid syndrome characterized by multiple features consistent with accelerated aging. Aberrant double-strand DNA damage repair leads to genomic instability and reduced replicative lifespan of somatic cells. We observed increased autophagy in WRN knockdown cells; this was further increased by short-term rapamycin treatment. Long-term rapamycin treatment resulted in improved growth rate, reduced accumulation of DNA damage foci and improved nuclear morphology; autophagy markers were reduced to near-normal levels, possibly due to clearance of damaged proteins. These data suggest that protein aggregation plays a role in the development of WS phenotypes and that the mammalian target of rapamycin complex 1 pathway is a potential therapeutic target of WS. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A
- Author
-
Huang, Shurong, Risques, Rosa Ana, Martin, George M., Rabinovitch, Peter S., and Oshima, Junko
- Subjects
- *
GENETIC mutation , *MORPHOLOGY , *FIBROBLASTS , *SYNDROMES - Abstract
Abstract: LMNA mutations are responsible for a variety of genetic disorders, including muscular dystrophy, lipodystrophy, and certain progeroid syndromes, notably Hutchinson-Gilford Progeria. Although a number of clinical features of these disorders are suggestive of accelerated aging, it is not known whether cells derived from these patients exhibit cellular phenotypes associated with accelerated aging. We examined a series of isogenic skin fibroblast lines transfected with LMNA constructs bearing known pathogenic point mutations or deletion mutations found in progeroid syndromes. Fibroblasts overexpressing mutant lamin A exhibited accelerated rates of loss of telomeres and shortened replicative lifespans, in addition to abnormal nuclear morphology. To our surprise, these abnormalities were also observed in lines overexpressing wild-type lamin A. Copy number variants are common in human populations; those involving LMNA, whether arising meiotically or mitotically, might lead to progeroid phenotypes. In an initial pilot study of 23 progeroid cases without detectable WRN or LMNA mutations, however, no cases of altered LMNA copy number were detected. Nevertheless, our findings raise a hypothesis that changes in lamina organization may cause accelerated telomere attrition, with different kinetics for overexpession of wild-type and mutant lamin A, which leads to rapid replicative senescence and progroid phenotypes. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
13. LMNA mutations in atypical Werner's syndrome.
- Author
-
Chen, Lishan, Lee, Lin, Kudlow, Brian A., Dos Santos, Heloisa G., Sletvold, Olav, Shafeghati, Yousef, Botha, Eleanor G., Garg, Abhimanyu, Hanson, Nancy B., Martin, George M., Mian, I. Saira, Kennedy, Brian K., and Oshima, Junko
- Subjects
- *
WERNER'S syndrome , *SYNDROMES , *PROGERIA , *GENETIC mutation , *DISEASES - Abstract
Background Werner's syndrome is a progeroid syndrome caused by mutations at the WRN helicase locus. Some features of this disorder are also present in laminopathies caused by mutant LMNA encoding nuclear lamin A/C. Because of this similarity, we sequenced LMNA in individuals with atypical Werner's syndrome (wild-type WRN). Methods Of 129 index patients referred to our international registry for molecular diagnosis of Werner's syndrome, 26 (20%) had wildtype WRN coding regions and were categorised as having atypical Werner's syndrome on the basis of molecular criteria. We sequenced all exons of LMNA in these individuals. Mutations were confirmed at the mRNA level by RT-PCR sequencing. In one patient in whom an LMNA mutation was detected and fibroblasts were available, we established nuclear morphology and subnuclear localisation. Findings In four (15%) of 26 patients with atypical Werner's syndrome, we noted heterozygosity for novel missense mutations in LMNA, specifically A57P, R133L (in two people), and L140R. The mutations altered relatively conserved residues within lamin A/C. Fibroblasts from the patient with the L140R mutation had a substantially enhanced proportion of nuclei with altered morphology and mislocalised lamins. Individuals with atypical Werner's syndrome with mutations in LMNA had a more severe phenotype than did those with the disorder due to mutant WRN. Interpretation Our findings indicate that Werner's syndrome is molecularly heterogeneous, and a subset of the disorder can be judged a laminopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.